Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 64–64 | Cite as

Azacitidine

De novo acute myeloid leukaemia: case report
Case report

Reference

  1. Ruggiu M, et al. Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia. Leukemia and Lymphoma 59: 1659-1665, No. 7, 3 Jul 2018. Available from: URL: http://doi.org/10.1080/10428194.2017.1397666 - FranceCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations